APPLICATION NUMBER
`12/137,356
`
`FILING OR 3 71 (C) DATE
`06/11/2008
`
`31834
`BRACCO RESEARCH USA INC.
`Intellectual Property Dept.
`305 COLLEGE ROAD EAST
`PRINCETON, NJ 08540
`
`Ul\TfED STATES DEPA RTME'IT OF COMMERCE
`United States Patent and Trademark Office
`Adiliess. COMMISSIO'JER FOR PATENTS
`PO Box 1450
`Alexandria, Virgmia 22313-1450
`\VVi\V.USpto.gov
`
`FIRST NAMED APPLICANT
`Charles R. Quirico
`
`ATTY. DOCKET NO./TITLE
`RB113 US
`CONFIRMATION NO. 7360
`POA ACCEPTANCE LETTER
`
`11111111111111111 lllll ll]~!l]!~l!~l!~Hi~Ul!lill lllll lllll lllll llll llll
`
`Date Mailed: 09/05/2013
`
`NOTICE OF ACCEPTANCE OF POWER OF ATTORNEY
`
`This is in response to the Power of Attorney filed 08/28/2013.
`
`The Power of Attorney in this application is accepted. Correspondence in this application will be mailed to the
`above address as provided by 37 CFR 1.33.
`
`/dtvernon/
`
`Office of Data Management, Application Assistance Unit (571) 272-4000, or (571) 272-4200, or 1-888-786-0101
`
`page 1 of 1
`
`JUBILANT EXHIBIT 1006
`Jubilant v. Bracco, IPR2018-01449
`
`1 of 1754
`
`

`

`APPLICATION NUMBER
`12/137,356
`
`FILING OR 3 71 (C) DATE
`06/11/2008
`
`22859
`FREDRIKSON & BYRON, P.A.
`INTELLECTUAL PROPERTY GROUP
`200 SOUTH SIXTH STREET, SUITE 4000
`MINNEAPOLIS, MN 55402
`
`Ul\TfED STATES DEPA RTME'IT OF COMMERCE
`United States Patent and Trademark Office
`Adiliess. COMMISSIO'JER FOR PATENTS
`PO Box 1450
`Alexandria, Virgmia 22313-1450
`\VVi\V.USpto.gov
`
`FIRST NAMED APPLICANT
`Charles R. Quirico
`
`ATTY. DOCKET NO./TITLE
`56782.1.5
`CONFIRMATION NO. 7360
`POWER OF ATTORNEY NOTICE
`
`11111111111111111 lllll ll]~!l]!~l!~l!~Hi~Hiil~ll lllll 111111111111111111
`
`Date Mailed: 09/05/2013
`
`NOTICE REGARDING CHANGE OF POWER OF ATTORNEY
`
`This is in response to the Power of Attorney filed 08/28/2013.
`
`• The Power of Attorney to you in this application has been revoked by the assignee who has intervened as
`provided by 37 CFR 3.71. Future correspondence will be mailed to the new address of record(37 CFR 1.33).
`
`/dtvernon/
`
`Office of Data Management, Application Assistance Unit (571) 272-4000, or (571) 272-4200, or 1-888-786-0101
`
`page 1 of 1
`
`2 of 1754
`
`

`

`PTO/SB/81A (12--08)
`Approved for u~e thrm,gh 11/30/2011. OMS 0651-0035
`U.S. Petem am.i Trademark Office,; U.S. DEPARTMENl' OF COMMERCE
`Under the Paper,vork Reduction /\c;l of 1995, no per5ons are required tc respond to a collecUcn cf ir,formation unless it displays a valid OMS control number.
`. ....,
`
`Patent Number
`
`8,317,674
`
`I"
`
`PATENT~ POWER OF ATTORNEY
`OR
`REVOCATION OF POWER OF ATTORNEY
`WITH A NEW POWER OF ATTORNEY
`AND
`CHANGE OF CORRESPONDENCE ADDRESS Attorney Docket Number RB1i3 US
`
`Issue Date
`
`First Named Inventor
`
`11/27/2012
`Charles R. QUIRICO
`
`Title
`
`Shielding Assemblies For Infusion
`Systems
`
`! hereby revoke all previous powers of attorney given 1n the above-identified patent.
`[·····1 A Power of Attorney is submitied herewith.
`OR
`[g]
`
`l hereby appoint Practltioner(s} associated with the following Customer Number as my/our
`attomey(s) or agent(s) with respect to the patent identified above, and to transact all business in
`the United States Patent and Trademark Office connected therewith:
`
`OR
`
`31,834
`
`I
`
`I
`D l hereby appoint Practitioner(s) named below as my/our a!torney(s) or agent(s) with respect to the patent identified
`
`above, and to transact all business in the United States Patent and Trademark Office connected therewith:
`
`Practltioner(s) Name
`
`Registration Number
`
`Please recognize or change the correspondence address for the above-identified patent to:
`!Xi The address associated wi!h the above-men!ioned Customer Number.
`- · -·
`OR
`
`~
`
`,._________, The address associated with Customer Number:
`OR
`Firm or
`:
`i
`- · -· Individual Name
`Address
`
`I
`
`City
`Country
`Telephone
`
`I State
`
`I Email
`
`I
`I
`
`I Zip I
`
`lam the:
`
`D Inventor, having ownership of the paten!.
`OR
`[8] Patent owner.
`Statement under 37 CFR 3. 73(b) (Form PTOISB/913) submitted herewith or fiied on
`
`Signature
`
`~ RE of lnvimtor or Patent Owm,r
`-
`
`I Date
`I Au~ust' 26. 2013
`I Telephone I (eoe) 514.2so3
`
`Anthony P. TlnBri
`Name
`Title and Company Vice President & General Counsel of Bracco Diagnostics Inc.
`N.Qili: Signature,a of ali lhe inventors or paten! owners of the entire interest er the,lr representalive{s) are required. Submit muitlple, form, If more than one
`signature is requ!re,d, see be!ow'.
`[·····1
`
`"Total of
`
`forms are submitted.
`
`This rollec!!on of informaton is required by 37 CFR 1.3'1, 1.32 and 1.33. The Information Is required to obtain or retain a benefit by the public which Is to fl!e (and by !tie
`USPTO kl palC8$~) .-i111:1p;.,llt1:1tion. Cm,f:danl!ality Is govamad by 35 U.S.C. 122 and 37 CFR 1.11 and 1.14. Tl,is ,iollactir.m is l:1$timated to t11ke 3 minutes to ctimple!e,
`including gathering, preparing, and submitting the completed application form to the, USPTO. Time will vary depending upon the Individual case. Any comments on
`the smownt of time you require to compieta thi~ form and/or suggestion~ for reducing this burdan, should be sant lo tha Chl!!f lnform.-itlon Offitar, U.S. Patent and
`Tr.id1:1m11rx Offlr;e, U.S. Deparlmen! of Commerce, P.O. Box 1450, Ale~amirh,1, VA 22313-1450. DO NOT SEND FEES OR COMPLETED FORMS TO THIS
`ADDRESS. SEND TO; Commissioner for Patents, P,O, Box 1450, Alexandria, VA 22313-1450.
`If.you need assistance in completing the form, call 1-IJOO·PT0-9199 and select option 2.
`
`3 of 1754
`
`

`

`Privacy Act Statement
`
`The Privacy Act of 1974 {PL 93-579} requires that you be given certain information in connection
`with your submission of the attached form related to a patent application or patent Accordingly,
`pursuant to the requirements of the Act, please be advised that: (1) the general authority for the
`collection of this information is 35 U.S.C. 2(b )(2); (2} furnishing of the information solicited is voluntary;
`and (3) the principal purpose for which the information is used by the U.S. Patent and Trademark
`Office is to process and/or examine your submission related to a patent application or patent. If you do
`not furnish the requested information, the U.S. Patent and Trademark Office may not be able to
`process andior examine your submission, which may result in termination of proceedings or
`abandonment of the application or expiration of the patent
`
`The information provided by you in this form will be subject to the following routine uses:
`
`1. The information on this form will be treated confidentially to the extent allowed under the
`Freedom of Information Act (5 U.S.C. 552) and the Privacy Act (5 U.S,C 552a}. Records from
`this system of records may be disclosed to the Department of Justice to determine whether
`disclosure of these records is required by the Freedom of Information Act.
`2. A record from this system of records may be disclosed, as a routine use, in the course of
`presenting evidence to a court, magistrate, or administrative tribunal, including disclosures to
`opposing counsel in the course of settlement negotiations.
`3. A record in this system of records may be disclosed, as a routine use, to a Member of
`Congress submitting a request involving an individual, to whom the record pertains, when the
`individual has requested assistance from the Member with respect to the subject matter of the
`record.
`4. A record in this system of records may be disclosed, as a routine use, to a contractor of the
`Agency having need for the information in order to perform a contract Recipients of
`information shall be required to comply with the requirements of the Privacy Act of 1974, as
`amended, pursuant to 5 U.S.C. 552a(m).
`5. A record related to an International Application flied under the Patent Cooperation Treaty in
`this system of records may be disclosed, as a routine use, to the International Bureau of the
`World Intellectual Property Organization, pursuant to the Patent Cooperation Treaty.
`6. A record in this system of records may be disclosed, as a routine use, to another federal
`agency for purposes of National Security review (35 U.S.C. 181) and for review pursuant to
`the Atomic Energy Act (42 U.S.C. 218(c)).
`7. A record from this system of records may be disclosed, as a routine use, to the Administrator,
`General Services, or his/her designee, during an inspection of records conducted by GSA as
`part of that agency's responsibility to recommend improvements in records management
`practices and programs, under authority of 44 U.S.C. 2904 and 2906. Such disclosure shall
`be made in accordance with the GSA regulations governing inspection of records for this
`purpose, and any other relevant (i.e., GSA or Commerce) directive. Such disclosure shall not
`be used to make determinations about individuals.
`8. A record from this system of records may be disclosed, as a routine use, to the public after
`either publication of the application pursuant to 35 U.S.C. 122(b) or issuance of a patent
`pursuant to 35 U.S.C. 151. Further, a record may be disclosed, subject to tile limitations of 37
`CFR 1.14, as a routine use, to the public if the record was filed in an application which
`became abandoned or in which the proceedings were terminated and which application is
`referenced by either a published application, an application open to public inspection or an
`issued patent.
`9. A record from this system of records may be disclosed, as a routine use, to a Federal, State,
`or local law enforcement agency, if the USPTO becomes aware of a violation or potential
`violation of law or regulation.
`
`4 of 1754
`
`

`

`This correspondence is being electronically filed using the EFS-WEB Electronic Filing System of the United States Patent and Trademark Office on:
`PTO/SB/96 (07-09)
`Approved for use through 07/31/2012. 0MB 0651-0031
`August 28, 2013
`U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE
`Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it displays a valid 0MB control number.
`RB113 US
`
`STATEMENT UNDER 37 CFR 3.73(b)
`
`ApplicanUPatent owner:
`
`Bracco Diagnostics Inc.
`
`Application No./Patent No.: ___ 8_,3_1_7_,6_7_4 _________ Filed/Issue Date:
`
`11/27/2012
`
`Titled:
`
`Shielding Assemblies For Infusion Systems
`
`Bracco Diagnostics Inc.
`_____________________ ,a
`(Name of Assignee)
`
`corporation
`
`(Type of Assignee, e.g., corporation, partnership, university, government agency, etc.
`
`states that it is:
`
`1. D the assignee of the entire right, title, and interest in;
`2. D an assignee of less than the entire right, title, and interest in
`
`(The extent (by percentage) of its ownership interest is ____ %);or
`
`3. ~ the assignee of an undivided interest in the entirety of (a complete assignment from one of the joint inventors was made)
`
`the patent application/patent identified above, by virtue of either:
`
`A. ~ An assignment from the inventor(s) of the patent application/patent identified above. The assignment was recorded in
`, Frame 0780
`, or for which a
`the United States Patent and Trademark Office at Reel 021699
`copy therefore is attached.
`
`OR
`
`B. D A chain of title from the inventor(s), of the patent application/patent identified above, to the current assignee as follows:
`To: - - - - - - - - - - - - - - - - - - - -
`The document was recorded in the United States Patent and Trademark Office at
`Frame - - - - - - - - or for which a copy thereof is attached.
`
`1. From:
`
`Reel
`
`2. From:
`
`3. From:
`
`The document was recorded in the United States Patent and Trademark Office at
`Frame _______ _
`
`Reel
`
`or for which a copy thereof is attached.
`
`To:
`
`To:
`
`The document was recorded in the United States Patent and Trademark Office at
`Frame _______ _
`
`Reel
`
`or for which a copy thereof is attached.
`
`D
`
`Additional documents in the chain of title are listed on a supplemental sheet(s).
`
`~ As required by 37 CFR 3.73(b)(1 )(i), the documentary evidence of the chain of title from the original owner to the assignee was,
`or concurrently is being, submitted for recordation pursuant to 37 CFR 3.11.
`
`[NOTE: A separate copy (i.e., a true copy of the original assignment document(s)) must be submitted to Assignment Division in
`accordance with 37 CFR Part 3, to record the assignment in the records of the USPTO. See MPEP 302.08]
`
`The undersigned (whose title is supplied below) is authorized to act on behalf of the assignee.
`
`/M. Caragh Noone, Reg. No. 37,197/
`
`Signature
`
`August28,2013
`
`Date
`
`M. Caragh Noone
`Title
`Printed or Typed Name
`This collection of information is required by 37 CFR 3.73(b). The information is required to obtain or retain a benefit by the public which is to file (and by the USPTO to
`process) an application. Confidentiality is governed by 35 U .S.C. 122 and 37 CFR 1.11 and 1.14. This collection is estimated to take 12 minutes to complete, including
`gathering, preparing, and submitting the completed application form to the USPTO. Time will vary depending upon the individual case. Any comments on the amount of time
`you require to complete this form and/or suggestions for reducing this burden, should be sent to the Chief Information Officer, U.S. Patent and Trademark Office, U.S.
`Department of Commerce, P.O. Box 1450, Alexandria, VA 22313-1450. DO NOT SEND FEES OR COMPLETED FORMS TO THIS ADDRESS. SEND TO: Commissioner
`for Patents, P.O. Box 1450, Alexandria, VA 22313-1450.
`
`US Chief Patent Counsel for Bracco Research USA Inc.
`
`If you need assistance in completing the form, ca/11-800-PT0-9199 and select option 2.
`
`5 of 1754
`
`

`

`Privacy Act Statement
`
`The Privacy Act of 1974 (P.L. 93-579) requires that you be given certain information in connection
`with your submission of the attached form related to a patent application or patent. Accordingly,
`pursuant to the requirements of the Act, please be advised that: (1) the general authority for the
`collection of this information is 35 U.S.C. 2(b)(2); (2) furnishing of the information solicited is voluntary;
`and (3) the principal purpose for which the information is used by the U.S. Patent and Trademark
`Office is to process and/or examine your submission related to a patent application or patent. If you do
`not furnish the requested information, the U.S. Patent and Trademark Office may not be able to
`process and/or examine your submission, which may result in termination of proceedings or
`abandonment of the application or expiration of the patent.
`
`The information provided by you in this form will be subject to the following routine uses:
`
`1. The information on this form will be treated confidentially to the extent allowed under the
`Freedom of Information Act (5 U.S.C. 552) and the Privacy Act (5 U.S.C 552a). Records from
`this system of records may be disclosed to the Department of Justice to determine whether
`disclosure of these records is required by the Freedom of Information Act.
`2. A record from this system of records may be disclosed, as a routine use, in the course of
`presenting evidence to a court, magistrate, or administrative tribunal, including disclosures to
`opposing counsel in the course of settlement negotiations.
`3. A record in this system of records may be disclosed, as a routine use, to a Member of
`Congress submitting a request involving an individual, to whom the record pertains, when the
`individual has requested assistance from the Member with respect to the subject matter of the
`record.
`4. A record in this system of records may be disclosed, as a routine use, to a contractor of the
`Agency having need for the information in order to perform a contract. Recipients of
`information shall be required to comply with the requirements of the Privacy Act of 1974, as
`amended, pursuant to 5 U.S.C. 552a(m).
`5. A record related to an International Application filed under the Patent Cooperation Treaty in
`this system of records may be disclosed, as a routine use, to the International Bureau of the
`World Intellectual Property Organization, pursuant to the Patent Cooperation Treaty.
`6. A record in this system of records may be disclosed, as a routine use, to another federal
`agency for purposes of National Security review (35 U.S.C. 181) and for review pursuant to
`the Atomic Energy Act (42 U.S.C. 218(c)).
`7. A record from this system of records may be disclosed, as a routine use, to the Administrator,
`General Services, or his/her designee, during an inspection of records conducted by GSA as
`part of that agency's responsibility to recommend improvements in records management
`practices and programs, under authority of 44 U.S.C. 2904 and 2906. Such disclosure shall
`be made in accordance with the GSA regulations governing inspection of records for this
`purpose, and any other relevant (i.e., GSA or Commerce) directive. Such disclosure shall not
`be used to make determinations about individuals.
`8. A record from this system of records may be disclosed, as a routine use, to the public after
`either publication of the application pursuant to 35 U.S.C. 122(b) or issuance of a patent
`pursuant to 35 U.S.C. 151. Further, a record may be disclosed, subject to the limitations of 37
`CFR 1.14, as a routine use, to the public if the record was filed in an application which
`became abandoned or in which the proceedings were terminated and which application is
`referenced by either a published application, an application open to public inspection or an
`issued patent.
`9. A record from this system of records may be disclosed, as a routine use, to a Federal, State,
`or local law enforcement agency, if the USPTO becomes aware of a violation or potential
`violation of law or regulation.
`
`6 of 1754
`
`

`

`PTO/SB/47 (03-09)
`Approved for use through 05/31/2015. 0MB 0651-0016
`U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE
`Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it displays a valid 0MB control number.
`
`[
`
`"FEE ADDRESS" INDICATION FORM
`
`]
`
`Address to:
`Mail Stop M Correspondence
`Commissioner for Patents
`P.O. Box 1450
`Alexandria, VA 22313-1450
`
`Fax to:
`571-273-6500
`
`-OR-
`
`INSTRUCTIONS: The issue fee must have been paid for application(s) listed on this form. In addition,
`only an address represented by a Customer Number can be established as the fee address for maintenance
`fee purposes (hereafter, fee address). A fee address should be established when correspondence related to
`maintenance fees should be mailed to a different address than the correspondence address for the application.
`When to check the first box below: If you have a Customer Number to represent the fee address. When
`to check the second box below: If you have no Customer Number representing the desired fee address,
`in which case a completed Request for Customer Number (PTO/SB/125) must be attached to this form. For
`more information on Customer Numbers, see the Manual of Patent Examining Procedure (MPEP) § 403.
`
`For the following listed application(s), please recognize as the "Fee Address" under the provisions of 37 CFR
`1.363 the address associated with:
`
`0 Customer Number: 131,834
`
`I
`
`OR
`D The attached Request for Customer Number (PTO/SB/125) form.
`
`PATENT NUMBER
`(if known)
`
`8,317,674
`
`APPLICATION NUMBER
`
`12/137,356
`
`Completed by (check one):
`
`D Applicant/Inventor
`
`0 Attorney or Agent of record
`
`37,197
`(Reg. No.)
`
`D Assignee of record of the entire interest. See 37 CFR 3.71.
`
`Statement under 37 CFR 3.73(b) is enclosed.
`(Form PTO/SB/96)
`
`D Assignee recorded at Reel
`
`Frame
`
`/M. Caragh Noone, Reg. No. 37,197/
`Signature
`
`M. Caragh Noone
`Typed or printed name
`
`(609) 514-2454
`Requester's telephone number
`
`August 28, 2013
`Date
`
`NOTE: Signatures of all the inventors or assignees of record of the entire interest or their representative(s) are required. Submit multiple forms if more that one
`signature is required, see below*.
`D
`• Total of
`This collection of information Is required by 37 CFR 1.363. The information Is required to obtain or retain a benefit by the public which Is to file (and by the USPTO
`to process) an application. Confidentiality is governed by 35 U.S.C. 122 and 37 CFR 1. 11 and 1.14. This collection is estima led to take 5 minutes to complete,
`including gathering, preparing, and submitting the completed application form to the USPTO. Time will vary depending upon the individual case. Any comments on
`the amount of time you require to complete this form and/or suggestions for reducing this burden, should be sent to the Chief Information Officer, U.S. Patent and
`Trademark Office, U.S. Department of Commerce, P.O. Box 1450, Alexandria, VA 22313- 1450. DO NOT SEND COMPLETED FORMS TO THIS A DDRESS.
`SEND TO: Mail Stop M Correspondence, Commissioner for Patents, P.O. Box 1450, Alexandria, VA 22313-1450.
`If you need assistance in completing the form, ca/11-800-PT0-9199 and select option 2.
`
`forms are submitted.
`
`7 of 1754
`
`

`

`Privacy Act Statement
`
`The Privacy Act of 1974 (P.L. 93-579) requires that you be given certain information in connection
`with your submission of the attached form related to a patent application or patent. Accordingly,
`pursuant to the requirements of the Act, please be advised that: (1) the general authority for the
`collection of this information is 35 U.S.C. 2(b)(2); (2) furnishing of the information solicited is voluntary;
`and (3) the principal purpose for which the information is used by the U.S. Patent and Trademark
`Office is to process and/or examine your submission related to a patent application or patent. If you do
`not furnish the requested information, the U.S. Patent and Trademark Office may not be able to
`process and/or examine your submission, which may result in termination of proceedings or
`abandonment of the application or expiration of the patent.
`
`The information provided by you in this form will be subject to the following routine uses:
`
`1. The information on this form will be treated confidentially to the extent allowed under the
`Freedom of Information Act (5 U.S.C. 552) and the Privacy Act (5 U.S.C 552a). Records from
`this system of records may be disclosed to the Department of Justice to determine whether
`disclosure of these records is required by the Freedom of Information Act.
`2. A record from this system of records may be disclosed, as a routine use, in the course of
`presenting evidence to a court, magistrate, or administrative tribunal, including disclosures to
`opposing counsel in the course of settlement negotiations.
`3. A record in this system of records may be disclosed, as a routine use, to a Member of
`Congress submitting a request involving an individual, to whom the record pertains, when the
`individual has requested assistance from the Member with respect to the subject matter of the
`record.
`4. A record in this system of records may be disclosed, as a routine use, to a contractor of the
`Agency having need for the information in order to perform a contract. Recipients of
`information shall be required to comply with the requirements of the Privacy Act of 1974, as
`amended, pursuant to 5 U.S.C. 552a(m).
`5. A record related to an International Application filed under the Patent Cooperation Treaty in
`this system of records may be disclosed, as a routine use, to the International Bureau of the
`World Intellectual Property Organization, pursuant to the Patent Cooperation Treaty.
`6. A record in this system of records may be disclosed, as a routine use, to another federal
`agency for purposes of National Security review (35 U.S.C. 181) and for review pursuant to
`the Atomic Energy Act (42 U.S.C. 218(c)).
`7. A record from this system of records may be disclosed, as a routine use, to the Administrator,
`General Services, or his/her designee, during an inspection of records conducted by GSA as
`part of that agency's responsibility to recommend improvements in records management
`practices and programs, under authority of 44 U.S.C. 2904 and 2906. Such disclosure shall
`be made in accordance with the GSA regulations governing inspection of records for this
`purpose, and any other relevant (i.e., GSA or Commerce) directive. Such disclosure shall not
`be used to make determinations about individuals.
`8. A record from this system of records may be disclosed, as a routine use, to the public after
`either publication of the application pursuant to 35 U.S.C. 122(b) or issuance of a patent
`pursuant to 35 U .S.C. 151. Further, a record may be disclosed, subject to the limitations of 37
`CFR 1.14, as a routine use, to the public if the record was filed in an application which
`became abandoned or in which the proceedings were terminated and which application is
`referenced by either a published application, an application open to public inspection or an
`issued patent.
`9. A record from this system of records may be disclosed, as a routine use, to a Federal, State,
`or local law enforcement agency, if the USPTO becomes aware of a violation or potential
`violation of law or regulation.
`
`8 of 1754
`
`

`

`Electronic Acknowledgement Receipt
`
`EFSID:
`
`Application Number:
`
`16707283
`
`12137356
`
`International Application Number:
`
`Confirmation Number:
`
`7360
`
`Title of Invention:
`
`SHIELDING ASSEMBLIES FOR INFUSION SYSTEMS
`
`First Named Inventor/Applicant Name:
`
`Charles R. Quirico
`
`Customer Number:
`
`22859
`
`Filer:
`
`Mary Caragh Noone/Pamela Gewirtz
`
`Filer Authorized By:
`
`Mary Caragh Noone
`
`Attorney Docket Number:
`
`56782.1.5
`
`Receipt Date:
`
`Filing Date:
`
`Time Stamp:
`
`28-AUG-2013
`
`11-JUN-2008
`
`13:04:33
`
`Application Type:
`
`Utility under 35 USC 111 (a)
`
`Payment information:
`
`Submitted with Payment
`
`I no
`
`File Listing:
`
`Document
`Number
`
`Document Description
`
`File Name
`
`File Size(Bytes)/
`Message Digest
`
`Multi
`Part /,zip
`
`Pages
`(if appl.)
`
`1
`
`Miscellaneous Incoming Letter
`
`8-28-13_a_ Transmittal_sb21 _R
`B113-US.pdf
`
`297408
`
`fbb29c34c7c3509feec5a0d54f5e44a727f8
`c17
`
`no
`
`2
`
`Warnings:
`
`Information:
`
`9 of 1754
`
`

`

`2
`
`Power of Attorney
`
`Warnings:
`
`8-28-13_b_xcutedPOA_RB113-
`US00P.pdf
`
`47863
`
`no
`
`2
`
`4c4f96e 759b204ecbcac1 65c5bf000dff647(
`053
`
`The page size in the PDF is too large. The pages should be 8.5 x 11 or A4. If this PDF is submitted, the pages will be resized upon entry into the
`Image File Wrapper and may affect subsequent processing
`
`Information:
`
`3
`
`Assignee showing of ownership per 37
`CFR 3.73.
`
`8-28-13_c_StmntUnder37cfr3-7
`3b_sb96_RB 113-US.pdf
`
`793008
`
`no
`
`2
`
`6e2be 101926c78466f616f1 f1f693ff9eb0fc1
`7c
`
`Warnings:
`
`Information:
`
`4
`
`Change of Address
`
`8-28-13_d_FeeAddresslndicati
`on_sb47 _RBl 13-US.pdf
`
`210717
`
`7 afff3 a6a2efb9 5e859d ab8e40df85be 1 b2 o,
`314
`
`no
`
`2
`
`Warnings:
`
`Information:
`
`Total Files Size (in bytes)
`
`1348996
`
`This Acknowledgement Receipt evidences receipt on the noted date by the USPTO of the indicated documents,
`characterized by the applicant, and including page counts, where applicable. It serves as evidence of receipt similar to a
`Post Card, as described in MPEP 503.
`
`New A~~lications Under 35 U.S.C. 111
`If a new application is being filed and the application includes the necessary components for a filing date (see 37 CFR
`1.53(b)-(d) and MPEP 506), a Filing Receipt (37 CFR 1.54) will be issued in due course and the date shown on this
`Acknowledgement Receipt will establish the filing date of the application.
`
`National Stage of an International A~~lication under 35 U.S.C. 371
`If a timely submission to enter the national stage of an international application is compliant with the conditions of 35
`U.S.C. 371 and other applicable requirements a Form PCT/DO/EO/903 indicating acceptance of the application as a
`national stage submission under 35 U.S.C. 371 will be issued in addition to the Filing Receipt, in due course.
`
`New International A~~lication Filed with the USPTO as a Receiving Office
`If a new international application is being filed and the international application includes the necessary components for
`an international filing date (see PCT Article 11 and MPEP 181 O), a Notification of the International Application Number
`and of the International Filing Date (Form PCT/RO/1 OS) will be issued in due course, subject to prescriptions concerning
`national security, and the date shown on this Acknowledgement Receipt will establish the international filing date of
`the application.
`
`10 of 1754
`
`

`

`Doc Code: TRAN.LET
`Document Description: Transmittal Letter
`
`PTO/SB/21 (07-09)
`Approved for use through 07/31/2012. 0MB 0651-0031
`U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE
`.
`.
`.
`.
`
`TRANSMITTAL
`FORM
`
`(to be used for all correspondence after initial filing)
`
`Total Number of Pages in This Submission
`
`7
`
`Filing Date
`
`6/11/06, issued 11/27/2012
`
`First Named Inventor
`
`Charles R. QUI RICO
`
`Art Unit
`
`Examiner Name
`
`3735
`
`Samuel G. GILBERT
`
`Attorney Docket Number
`
`RB113 US
`
`ENCLOSURES
`
`(Check all that apply)
`
`D
`D
`
`After Final
`
`Provisional Application
`
`Affidavits/declaration(s)
`
`Change of Correspondence Address
`
`D After Allowance Communication to TC
`D Appeal Communication to Board
`D Appeal Communication to TC
`D
`D Status Letter
`0
`
`of Appeals and Interferences
`
`(Appeal Notice, Brief, Reply Brief)
`
`Proprietary Information
`
`Other Enclosure(s) (please Identify
`below):
`Forms PTO/SB/81 A; PTO/SB/96; and
`PTO/SB/47
`
`D
`
`D
`
`Fee Transmittal Form
`
`Drawing(s)
`
`D
`
`Fee Attached
`
`Amendment/Reply
`
`Extension of Time Request
`
`D
`D Licensing-related Papers
`D Petition
`D Petition to Convert to a
`~ Power of Attorney, Revocation
`D Terminal Disclaimer
`D
`D Express Abandonment Request D Request for Refund
`D Information Disclosure Statement D CD, Number of CD(s)
`D Landscape Table on CD
`I Remarks
`I
`No fee is believed due re: Revocation of PoA & Fee Address to request MF statements be
`mailed to Customer No. 31,834. However, if any fees are deemed necessary, the Director is
`hereby authorized to charge any required fees and credit any overpayments to Deposit Account
`No. 50-2168.
`
`Document(s)
`
`Reply to Missing Parts/
`
`D Certified Copy of Priority
`D Incomplete Application
`D Reply to Missing Parts
`
`under 37 CFR 1.52 or 1.53
`
`SIGNATURE OF APPLICANT, ATTORNEY, OR AGENT
`
`Firm Name
`
`Signature
`
`Printed name
`
`Date
`
`r
`
`/M. Caragh Noone, Reg. No. 37,197/
`
`M. Caragh Noone
`
`August28,2013
`
`I Reg. No. 137,197
`
`CERTIFICATE OF TRANSMISSION/MAILING
`
`I hereby certify that this correspondence is being facsimile transmitted to the USPTO or deposited with the United States Postal Service with
`sufficient postage as first class mail in an envelope addressed to: Commissioner for Patents, P.O. Box 1450, Alexandria, VA 22313-1450 on
`the date shown below:
`Signature
`
`Electronically Filed Using the EFS-WEB Electronic Filing System of the United States
`
`\ryped or printed name
`
`Patent and Trademark Office on:
`
`I Date I August 28, 2013
`
`""
`
`~
`
`This collection of information is required by 37 CFR 1.5. The information is required to obtain or retain a benefit by the public which is to file (and by the USPTO to
`process) an application. Confidentiality is governed by 35 U.S.C. 122 and 37 CFR 1.11 and1 .14. This collection is estimated to 2 hours to complete, including
`gathering, preparing, and submitting the completed application form to the USPTO. Time will vary depending upon the individual case. Any comments on the
`amount of time you require to complete this form and/or suggestions for reducing this burden, should be sent to the Chief Information Officer, U.S. Patent and
`Trademark Office, U.S. Department of Commerce, P.O. Box 1450, Alexandria, VA 22313-1450. DO NOT SEND FEES OR COMPLETED FORMS TO THIS
`ADDRESS. SEND TO: Commissioner for Patents, P.O. Box 1450, Alexandria, VA 22313-1450.
`
`If you need assistance in completing the form, ca/11-800-PTO-9199 and select option 2.
`
`11 of 1754
`
`

`

`Privacy Act Statement
`
`The Privacy Act of 1974 (P.L. 93-579) requires that you be given certain information in connection
`with your submission of the attached form related to a patent application or patent. Accordingly,
`pursuant to the requirements of the Act, please be advised that: (1) the general authority for the
`collection of this information is 35 U.S.C. 2(b)(2); (2) furnishing of the information solicited is voluntary;
`and (3) the principal purpose for which the information is used by the U.S. Patent and Trademark
`Office is to process and/or examine your submission related to a patent application or patent. If you do
`not furnish the requested information, the U.S. Patent and Trademark Office may not be able to
`process and/or examine your submission, whic